Action CEMI CHEMBIO DIAGNOSTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Chembio Diagnostics, Inc.

Actions

CEMI

US1635722093

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Chembio Diagnostics, Inc. acquired FastPack® diagnostics business from Qualigen Therapeutics, Inc. for $5.8 million.
CHEMBIO DIAGNOSTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc.(NasdaqCM:CEMI) dropped from NASDAQ Composite Index
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023
CHEMBIO DIAGNOSTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Chembio’s CEO Letter to Stockholders
CHEMBIO DIAGNOSTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Biosynex : OPA prolongée sur Chembio Diagnostics
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt
CHEMBIO DIAGNOSTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CEMI
  4. Actualités Chembio Diagnostics, Inc.
  5. Autres langues